Our in vivo data of IHC staining of human CIN and invasive carcinoma, and mouse cervical cancer models demonstrated that increases in AIB1 correlated with clinical staging, suggesting a potential biomarker for cervical cancer progression. The gene discussed is NCOA3; the disease is invasive carcinoma.